<DOC>
	<DOCNO>NCT00689494</DOCNO>
	<brief_summary>Measure blood progesterone use cervical device contraception .</brief_summary>
	<brief_title>Cervical Device Contraception-2 ( Nanopaz )</brief_title>
	<detailed_description>A small cervical device release small amount progesterone 20 mcgm/day . The target research measure blood progesterone use cervical device . This small device delivers progesterone nanotechnology method .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>10 healthy woman candidate hysterectomy Women neoplastic malignancy disease thrombophylia</criteria>
	<gender>Female</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>2 Months</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Nanopaz device</keyword>
	<keyword>Blood progesterone measure use device</keyword>
	<keyword>Delivery progesterone</keyword>
	<keyword>Progesterone levonorgestrel</keyword>
</DOC>